Early research (Phase 1)Ended earlyNCT04553692
What this trial is testing
Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers
Who this might be right for
Solid TumorColorectal CancerNon Hodgkin Lymphoma+5 more
IGM Biosciences, Inc. 272